HomeEmployersLyciatherapeutics
L

Lyciatherapeutics

4 open positions
Last updated Nov 12, 2026
Remote30%
Hybrid40%
On-site30%
Salary shown100%
Avg. listing160d
This month0 new · 1 closed

Clinical Research Associate

$125k–$150k/year
48
Low

Lycia Therapeutics (Nasdaq: LYCA) is a clinical-stage biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and develop therapeutics that degrade extracellular and membrane-bound proteins. These proteins drive a wide range of difficult-to-treat diseases

HealthcareClinical ResearcherFull-TimeMid
See 2 similar>
3 0 0 12d ago

Office Manager / Executive Assistant

$120k–$143k/year
39
Lowest

Lycia Therapeutics (Nasdaq: LYCA) is a clinical-stage biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and develop therapeutics that degrade extracellular and membrane-bound proteins. These proteins drive a wide range of difficult-to-treat diseases

Executive AssistantAdministration & Office SupportFull-TimeMid
See 2 similar>
2 0 0 12d ago

Senior Manager/Associate Director Clinical Operations

$175k–$202k/year
43
Low

Lycia Therapeutics (Nasdaq: LYCA) is a clinical-stage biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and develop therapeutics that degrade extracellular and membrane-bound proteins. These proteins drive a wide range of difficult-to-treat diseases

OtherClinical OperationsFull-TimeSenior
See 2 similar>
7 0 0 3mo ago

Vice President (VP) / Senior VP, Clinical Development

$360k–$420k/year
37
Lowest

Lycia Therapeutics (Nasdaq: LYCA) is a clinical-stage biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and develop therapeutics that degrade extracellular and membrane-bound proteins. These proteins drive a wide range of difficult-to-treat diseases

OtherDevelopmentSenior
See 2 similar>
3 0 0 6mo ago